Medigen Vaccine Biologics Free Cash Flow Generation Index

Latest as of December 2025: 0.97x

Medigen Vaccine Biologics free cash flow generation index. Medigen Vaccine Biologics (6547) has a Free Cash Flow Generation Index of 0.97x as of December 2025. Free cash flow of NT$97.54 Million represents 1% of operating cash flow (NT$101.08 Million).

FCF Generation Index

0.97x
Free Cash Flow / Operating CF

Free Cash Flow

NT$97.54 Million
TWD

Operating Cash Flow

NT$101.08 Million
TWD

Capital Expenditures

NT$3.54 Million
TWD

Free Cash Flow Generation Index of Medigen Vaccine Biologics (2015–2024)

Free cash flow generation index of Medigen Vaccine Biologics from 2015 to 2024. Historical FCF Generation Index trend for Medigen Vaccine Biologics across 3 annual periods. See how financially flexible is Medigen Vaccine Biologics to measure the company's free cash flow as a share of total liabilities.

Medigen Vaccine Biologics Free Cash Flow Generation Index by Year (2015–2024)

Medigen Vaccine Biologics free cash flow generation index by year from 2015 to 2024. Year-by-year Free Cash Flow Generation Index for Medigen Vaccine Biologics. For the full cash flow conversion analysis, see 6547 cash flow conversion.

Year FCG Index Free Cash Flow (TWD) Operating CF Capital Expenditures YoY Change
2024 0.14x NT$5.77 Million NT$40.75 Million NT$34.98 Million ▼ -81.5%
2021 0.77x NT$444.92 Million NT$579.89 Million NT$134.97 Million ▲ +168.9%
2015 -1.11x NT$-240.89 Million NT$216.26 Million NT$457.15 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).